The outbreak of Coronavirus (COVID-19) has provided a shock to both the Spanish economy and society and significantly impacted consumer health sales. While Spain has not suffered from obvious shortages of medicines, the stockpiling of certain products, especially analgesics and cough, cold and allergy (hay fever) remedies, has been observed.
Consumer Health in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Our reports have been used by over 10K customers, including:
94 pages •
By Euromonitor International
• Nov 2020
With Kenyans mired in the COVID-19 pandemic, it is perhaps not surprising that value sales of consumer health products are set to rise in 2020 at a rate higher than those recorded during the review period. Broadly, a pandemic-inspired heightened focus on maintaining/improving health is driving greater interest in over the counter (OTC) health...
111 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see increased current value growth in 2020. The spread of the COVID-19 pandemic has fuelled growth of immunity-boosting vitamins and dietary supplements, as well as topical germicidals/antiseptics in the year. Sleep aids have also benefited from increased levels of stress and anxiety as a result of COVID-19,...
85 pages •
By Euromonitor International
• Oct 2020
Consumer health is expected to see varied effects across a number of product areas in 2020 as a result of the COVID-19 pandemic. Analgesics and cough, cold and allergy (hay fever) remedies are expected to see spikes in retail current value growth in 2020 because of consumer stockpiling. Demand for these product areas is expected to increase...
111 pages •
By Euromonitor International
• Jan 2021
The emergence of the pandemic in Colombia and subsequent lockdown by the government in an attempt to control the spread of the virus resulted in rising unemployment and decreasing disposable incomes, and led to many local consumers prioritising their spending on essential purchases, including groceries and medicines. Consumer health therefore,...
119 pages •
By Euromonitor International
• Jan 2021
Consumer health has seen slightly higher growth overall in current value terms in 2020 compared to the previous year. Nevertheless, growth has remained largely in line with the review period average, with economic pressures preventing any more significant gains. When COVID-19 first appeared in South Africa there was some initial stockpiling...
113 pages •
By Euromonitor International
• Nov 2020
To mitigate the risk of contracting COVID-19 consumers in Japan have been confining themselves to their homes on a more regular basis, while they are also taking a more proactive approach to their health, focusing on prevention over treatment. This has resulted in contrasting fortunes for the various product categories within consumer health....
116 pages •
By Euromonitor International
• Jan 2021
In response to COVID-19 the Swiss government introduced a range of measures to limit the spread of the virus, with this having a mixed impact on the various categories of consumer health. Nonetheless, there was an overall improvement seen in 2020, spurred on by stronger sales in key categories including analgesics, cough, cold and allergy...
119 pages •
By Euromonitor International
• Jan 2021
COVID-19 had a significant impact on consumer health in Austria in 2020 with it resulting in consumers reassessing their priorities and focusing on their immediate concerns. As concerns rose about the threat posed by COVID-19 many households started stocking up on products that were perceived to treat the symptoms of the virus, such as analgesics...
125 pages •
By Euromonitor International
• Dec 2020
2020 has proven to be a fairly turbulent year for consumer health in Germany following the emergence of the pandemic. After the ‘’hamster’’ (stockpiling purchases) period in March due to various lockdown restrictions by the government in an effort to curb the spread of the virus, it was followed by a slump, with the market subsequently entering...
103 pages •
By Euromonitor International
• Nov 2020
The Malaysian Government implemented the Movement Control Order (MCO) from 18 March to 4 May in an effort to contain the spread of the COVID-19 pandemic in the country. There followed the Conditional Movement Control Order (CMCO) – between 4 May and 10 June, and the Recovery Movement Control Order (RMCO) – between 10 June and 31 August. All...
OTC
Dietary Supplement
Healthcare
Malaysia
Analgesic Medicine Sales
Vitamin Sales
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.